Cargando…

Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure　― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―

Background: The aim of the prospective post-marketing AF-CHF Landiolol Survey was to evaluate the safety and effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter in patients with cardiac dysfunction in clinical practice in Japan. This analysis reports mid-term progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Takeshi, Nakasu, Yukiko, Mizutani, Hiroto, Sumitani, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939785/ https://www.ncbi.nlm.nih.gov/pubmed/33693288 http://dx.doi.org/10.1253/circrep.CR-20-0119

Ejemplares similares

Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018)

Landiolol for managing post-operative atrial fibrillation
por: Balik, Martin, et al.
Publicado: (2018)

Landiolol for managing atrial fibrillation in post-cardiac surgery
por: Fellahi, Jean-Luc, et al.
Publicado: (2018)

Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction
por: von Haehling, Stephan, et al.
Publicado: (2018)

Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting
por: Domanovits, Hans, et al.
Publicado: (2018)

Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Preventive effect of low-dose landiolol on postoperative atrial fibrillation study (PELTA study)
por: Sasaki, Konosuke, et al.
Publicado: (2020)

Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
por: Aoki, Yoshitaka, et al.
Publicado: (2020)

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
por: Takahashi, Koji, et al.
Publicado: (2021)

Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients
por: Hariri, Geoffroy, et al.
Publicado: (2021)

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy
por: Dan, Gheorghe-Andrei
Publicado: (2022)

Landiolol for the prevention of postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis
por: Cafaro, Teresa, et al.
Publicado: (2023)

Preventive Effect of Intraoperative Landiolol Administration on Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting
por: Osumi, Masahiro, et al.
Publicado: (2014)

Safety and effective use of landiolol in the ICU
por: Hifumi, Toru, et al.
Publicado: (2014)

Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol
por: Nakanishi, Kazuhiro, et al.
Publicado: (2013)

Perioperative Landiolol Administration reduces Atrial Fibrillation after Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials
por: Sakamoto, Atsuhiro, et al.
Publicado: (2014)

Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients With Acute Decompensated Heart Failure With Severely Reduced Ejection Fraction
por: Iwahashi, Noriaki, et al.
Publicado: (2019)

Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis
por: Hao, Jianqi, et al.
Publicado: (2021)

Intravenous landiolol for the prevention of atrial fibrillation after aortic root, ascending aorta, and aortic arch surgery: A propensity score-matched analysis
por: Kaminohara, Jun, et al.
Publicado: (2022)

Study of hemodynamics in patients treated with landiolol in the ICU
por: Imabayashi, T, et al.
Publicado: (2009)

Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure
por: Shiga, Tsuyoshi
Publicado: (2022)

Erratum to: Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia
por: Kiuchi, Shunsuke, et al.
Publicado: (2017)

The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature
por: Bezati, Sofia, et al.
Publicado: (2022)

Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies
por: Ashida, Atsuko, et al.
Publicado: (2021)

Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
por: Gangl, Clemens, et al.
Publicado: (2022)

Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial
por: Caspersen, Edouard, et al.
Publicado: (2023)

Efficacy and safety of cardioversion with continuous landiolol infusion for atrial tachyarrhythmia in an inflammatory state caused by volvulus in a child with TARP syndrome and postoperative tetralogy of Fallot
por: Miyamoto, Kenji, et al.
Publicado: (2018)

Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction
por: Wada, Yuko, et al.
Publicado: (2016)

Effect of landiolol on sex-related transcriptomic changes in the myocardium during sepsis
por: Tran, Thi Thom, et al.
Publicado: (2019)

Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults
por: Krumpl, Günther, et al.
Publicado: (2020)

Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model
por: Hirano, Masaharu, et al.
Publicado: (2021)

Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience
por: Matsui, Yuko, et al.
Publicado: (2019)

Landiolol, an intravenous β1‐selective blocker, is useful for dissociating a fusion of atrial activation via accessory pathway and atrioventricular node
por: Kinjo, Takahiko, et al.
Publicado: (2023)

Landiolol reduces hemodynamic responses to bronchoscopy-assisted suctioning in intubated ICU patients
por: Tochikubo, Junpei, et al.
Publicado: (2014)

Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension
por: Schroeder, Lukas, et al.
Publicado: (2022)

Efficacy and Safety of Landiolol in Patients With Ventricular Tachyarrhythmias With or Without Renal Impairment　― Subanalysis of the J-Land II Study ―
por: Shiga, Tsuyoshi, et al.
Publicado: (2020)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mo1rjlosde4b6osp1bqqijr41k